trustme.bro/r/ā€¦
āœ“ checked
trust me, bro:
here is the receipt.
the claim
Genetically modified viruses can be used to cure genetic diseases
the verdict
SUPPORTED
the evidence backs this
refutedsupported
the weight of evidence
5 sources for · 0 against

Genetically modified viral vectors, such as adeno-associated viruses (AAVs), are successfully used in preclinical and clinical settings to deliver therapeutic genetic material and gene-editing tools to treat and correct genetic diseases.

Evidence for · 5
Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases
2021 · cited by 166
Demonstrates that adeno-associated virus vectors can deliver gene-editing tools to correct pathogenic mutations and ameliorate disease phenotypes in animal models of genetic diseases.
See more details
The analysis

The retrieved papers consistently demonstrate that viral vectors (such as AAVs) can be used to deliver gene therapies and gene-editing technologies to correct genetic mutations, restore biochemical homeostasis, and improve phenotypes in animal models and clinical applications of genetic diseases. There is no contradictory evidence in the retrieved literature.

More for · 4
Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosides
2020 · cited by 21
Shows that AAV-mediated gene therapy restores biochemical homeostasis and improves functional phenotypes in a murine model of a genetic disorder.
Viral vector-based gene therapies in the clinic: An update.
2026 · cited by 1
Reviews FDA-approved viral vector-based gene therapies targeting various genetic and monogenic disorders, illustrating clinical translation.
Gene Therapy Using Recombinant Adeno-Associated Virus for Leber Congenital Amaurosis Induced by RPE65 Mutation.
2026 · cited by 0
Discusses the use of recombinant adeno-associated virus vectors to deliver functional genes to treat genetic retinal dystrophies like Leber congenital amaurosis.
Prime editing of a pathogenic <i>Scn1a</i> allele ameliorates seizure phenotypes in a GEFS<sup>+</sup> mouse model.
2026 · cited by 0
Demonstrates that AAV delivery of prime editing components corrects genetic mutation and ameliorates seizure phenotypes in a mouse model of an inherited epileptic disorder.
Everything we examined (12)
We also searched for evidence AGAINST this claim, not only for it.
  1. Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseasespeer-reviewedsupports
  2. Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosidespeer-reviewedsupports
  3. Viral vector-based gene therapies in the clinic: An update.peer-reviewedsupports
  4. Gene Editing Strategies for Neurological and Mental Disorders: Advances in Delivery, Methodology, and Clinical Translation.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  5. DNA and RNA editing for the therapy of human diseases: current status, challenges, and future prospects.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  6. Viral and non-viral cellular therapies for neurodegeneration.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  7. Gene Targeted Therapies for Neurodegenerative Disorders: Strategies and Implications in ALS and SMA.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  8. The emerging role of gene therapy in autism spectrum disorder.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  9. Gene therapy for Parkinson's disease: current landscape, translational challenges, and future directions.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  10. RNA Therapeutics Targeting Skeletal Muscle: Emerging Antisense and Gene-Modifying Strategies.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  11. Gene Therapy Using Recombinant Adeno-Associated Virus for Leber Congenital Amaurosis Induced by RPE65 Mutation.peer-reviewedsupports
  12. Prime editing of a pathogenic <i>Scn1a</i> allele ameliorates seizure phenotypes in a GEFS<sup>+</sup> mouse model.peer-reviewedsupports
The paper trail · every fact has a biography
first checked06 Aug 2026
judged → SUPPORTED · 8906 Aug 2026
This receipt carries no identity, shared or not. Sharing publishes your connection to it, not your data.
Check your own claim
Challenge the receipt
trust me, bro: win the argument, pass the class, survive peer review.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt